Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site

BMC Research Notes

Volumn 8, Issue 1, 2015, Pages

  Tessier, Sarah J ^a   Loiselle, Julie J ^a   McBain, Anne ^b   Pullen, Celine ^a   Koenderink, Benjamin W ^c   Roy, Justin G ^a   Sutherland, Leslie C ^a,c,d  

^a LAURENTIAN UNIVERSITY   (Canada)

^b Genetics Lab Health Sciences North   (Canada)

^c AMRIC Health Sciences North   (Canada)

^d UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Alternative splicing; NUMB; RBM10; Regulation; RNA binding protein; RRM

Indexed keywords

GLUTAMIC ACID; ISOPROTEIN; MEMBRANE PROTEIN; MESSENGER RNA; NERVE PROTEIN; NUMB PROTEIN, HUMAN; RBM10 PROTEIN, HUMAN; RNA BINDING PROTEIN; VALINE;

ALTERNATIVE RNA SPLICING; EXON; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LUNG TUMOR; MALE; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE MOTIF; PATHOLOGY; POINT MUTATION; PROTEIN SECONDARY STRUCTURE; PROTEIN TERTIARY STRUCTURE; SIGNAL TRANSDUCTION; SMALL CELL LUNG CANCER; TUMOR CELL LINE;

ALTERNATIVE SPLICING; CELL LINE, TUMOR; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAMIC ACID; HUMANS; LUNG NEOPLASMS; MALE; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; NUCLEOTIDE MOTIFS; POINT MUTATION; PROTEIN ISOFORMS; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; RNA, MESSENGER; RNA-BINDING PROTEINS; SIGNAL TRANSDUCTION; SMALL CELL LUNG CARCINOMA; VALINE;

EID: 84928660247     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/s13104-015-0983-5     Document Type: Article

References (28)

1. Inoue A, Yamamoto N, Kimura M, Nishio K, Yamane H, Nakajima K. RBM10 regulates alternative splicing. FEBS Lett. 2014;588:942-7.
2. Bechara EG, Sebestyen E, Bernardis I, Eyras E, Valcarcel J. RBM5, 6, and 10 Differentially Regulate NUMB Alternative Splicing to Control Cancer Cell Proliferation. Mol Cell. 2013;52:720-33.
3. Wang Y, Gogol-Doring A, Hu H, Frohler S, Ma Y, Jens M, et al. Integrative analysis revealed the molecular mechanism underlying RBM10-mediated splicing regulation. EMBO Mol Med. 2013;5:1431-42.
4. Mueller CF, Berger A, Zimmer S, Tiyerili V, Nickenig G. The heterogenous nuclear riboprotein S1-1 regulates AT1 receptor gene expression via transcriptional and posttranscriptional mechanisms. Arch Biochem Biophys. 2009;488:76-82.
5. Sutherland LC, Rintala-Maki ND, White RD, Morin CD. RNA binding motif (RBM) proteins: a novel family of apoptosis modulators? J Cell Biochem. 2005;94:5-24.
6. Johnston JJ, Teer JK, Cherukuri PF, Hansen NF, Loftus SK, Chong K, et al. Massively parallel sequencing of exons on the X chromosome identifies RBM10 as the gene that causes a syndromic form of cleft palate. Am J Hum Genet. 2010;86:743-8.
7. Gripp KW, Hopkins E, Johnston JJ, Krause C, Dobyns WB, Biesecker LG. Long-term survival in TARP syndrome and confirmation of RBM10 as the disease-causing gene. Am J Med Genet A. 2011;155A:2516-20.
8. Johnston JJ, Sapp JC, Curry C, Horton M, Leon E, Cusmano-Ozog K, et al. Expansion of the TARP syndrome phenotype associated with de novo mutations and mosaicism. Am J Med Genet A. 2014;164A:120-8.
9. Furukawa T, Kuboki Y, Tanji E, Yoshida S, Hatori T, Yamamoto M, et al. Whole-exome sequencing uncovers frequent GNAS mutations in intraductal papillary mucinous neoplasms of the pancreas. Sci Rep. 2011;1:161.
10. Imielinski M, Berger AH, Hammerman PS, Hernandez B, Pugh TJ, Hodis E, et al. Mapping the hallmarks of lung adenocarcinoma with massively parallel sequencing. Cell. 2012;150:1107-20.
11. Hiller M, Huse K, Szafranski K, Rosenstiel P, Schreiber S, Backofen R, et al. Phylogenetically widespread alternative splicing at unusual GYNGYN donors. Genome Biol. 2006;7:R65.
12. Smit EF, de Vries EG, Timmer-Bosscha H, de Leij LF, Oosterhuis JW, Scheper RJ, et al. In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data. Int J Cancer. 1992;51:72-8.
13. Nagase T, Seki N, Tanaka A, Ishikawa K, Nomura N. Prediction of the coding sequences of unidentified human genes. IV. The coding sequences of 40 new genes (KIAA0121-KIAA0160) deduced by analysis of cDNA clones from human cell line KG-1. DNA Res. 1995;2:167-210.
14. Coleman MP, Ambrose HJ, Carrel L, Nemeth AH, Willard HF, Davies KE. A novel gene, DXS8237E, lies within 20 kb upstream of UBE1 in Xp11.23 and has a different X inactivation status. Genomics. 1996;31:135-8.
15. Thiselton DL, McDowall J, Brandau O, Ramser J, d'Esposito F, Bhattacharya SS, et al. An integrated, functionally annotated gene map of the DXS8026-ELK1 interval on human Xp11.3-Xp11.23: potential hotspot for neurogenetic disorders. Genomics. 2002;79:560-72.
16. Song Z, Wu P, Ji P, Zhang J, Gong Q, Wu J, et al. Solution structure of the second RRM domain of RBM5 and its unusual binding characters for different RNA targets. Biochemistry. 2012;51:6667-78.
17. Kopp J, Schwede T. The SWISS-MODEL Repository of annotated three-dimensional protein structure homology models. Nucleic Acids Res. 2004;32:D230-4.
18. Kiefer F, Arnold K, Kunzli M, Bordoli L, Schwede T. The SWISS-MODEL Repository and associated resources. Nucleic Acids Res. 2009;37:D387-92.
19. Misquitta-Ali CM, Cheng E, O'Hanlon D, Liu N, McGlade CJ, Tsao MS, et al. Global profiling and molecular characterization of alternative splicing events misregulated in lung cancer. Mol Cell Biol. 2011;31:138-50.
20. Wang K, Bacon ML, Tessier JJ, Rintala-Maki ND, Tang V, Sutherland LC. RBM10 Modulates Apoptosis and Influences TNA-a Gene Expression. Journal of Cell Death. 2012;5:1-19.
21. Mourtada-Maarabouni M, Keen J, Clark J, Cooper CS, Williams GT. Candidate tumor suppressor LUCA-15/RBM5/H37 modulates expression of apoptosis and cell cycle genes. Exp Cell Res. 2006;312:1745-52.
22. Oh JJ, Razfar A, Delgado I, Reed RA, Malkina A, Boctor B, et al. 3p21.3 tumor suppressor gene H37/Luca15/RBM5 inhibits growth of human lung cancer cells through cell cycle arrest and apoptosis. Cancer Res. 2006;66:3419-27.
23. Zheng S, Damoiseaux R, Chen L, Black DL. A broadly applicable high-throughput screening strategy identifies new regulators of Dlg4 (Psd-95) alternative splicing. Genome Res. 2013;23:998-1007.
24. Sutherland LC, Edwards SE, Cable HC, Poirier GG, Miller BA, Cooper CS, et al. LUCA-15-encoded sequence variants regulate CD95-mediated apoptosis. Oncogene. 2000;19:3774-81.
25. Shu Y, Rintala-Maki ND, Wall VE, Wang K, Goard CA, Langdon CE, et al. The apoptosis modulator and tumour suppressor protein RBM5 is a phosphoprotein. Cell Biochem Funct. 2007;25:643-53.
26. Rintala-Maki ND, Abrasonis V, Burd M, Sutherland LC. Genetic instability of RBM5/LUCA-15/H37 in MCF-7 breast carcinoma sublines may affect susceptibility to apoptosis. Cell Biochem Funct. 2004;22:307-13.
27. Rintala-Maki ND, Goard CA, Langdon CE, Wall VE, Traulsen KE, Morin CD, et al. Expression of RBM5-related factors in primary breast tissue. J Cell Biochem. 2007;100:1440-58.
28. Rintala-Maki ND, Sutherland LC. LUCA-15/RBM5, a putative tumour suppressor, enhances multiple receptor-initiated death signals. Apoptosis. 2004;9:475-84.